A Study to Evaluate Ketamine to Treat Chronic Neuropathic Pain in Patients with Traumatic Brachial Plexus Injuries

Overview

Información sobre este estudio

The purpose of this study is to assess pre- and postoperative neuropathic pain in patients with traumatic brachial plexus injuries to determine if intraoperative ketamine infusion affect neuropathic pain associated with avulsion injuries of the brachial plexus. 

A secondary goal is to determine the duration of pain relief following ketamine infusions.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

- Patients with neuropathic pain associated with avulsion injuries following traumatic
brachial plexus injuries scheduled for brachial plexus exploration and reconstruction
by three senior surgeons at Mayo Clinic (AYS, ATB, RJS):

- Neuropathic pain defined as pain directly related to injury to the somatosensory
system, and score >4/10 on the Douleur Neuropathique en 4 Questions (DN4) neuropathic
pain questionnaire. Symptoms of neuropathic pain include allodynia, hyperalgesia,
burning, needle-like, throbbing, shooting, or electrical-type sensation.

- Nerve root avulsion on CT myelogram.

- Traumatic brachial plexus injuries defined as blunt or penetrating trauma resulting in
injury and dysfunction along the course of the brachial plexus defined as nerve roots
C5-T1, trunks, divisions, cords, and terminal branches.

Exclusion Criteria:

- Patients without pain following traumatic brachial plexus injuries.

- Patients with brachial plexus injuries due to non-traumatic causes such as tumors,
infection, radiation, or inflammatory disorders such as Parsonage Turner Syndrome.

- Patients who do not require surgery for exploration/reconstruction at the brachial
plexus.

- Patients under 18 years of age.

- Contraindication to ketamine use (severe hepatic dysfunction -cirrhosis, high-risk
coronary artery disease, poorly controlled psychiatric condition- schizophrenia.

Eligibility last updated 6/21/22. Questions regarding updates should be directed to the study team contact.

 

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Alexander Shin, M.D.

Abierto para la inscripción

Contact information:

Courtney Carlson Strother M.D.

Carlson.Courtney@mayo.edu

More information

Publicaciones

Publications are currently not available
.
CLS-20526009

Mayo Clinic Footer